|
|
aantal stemrechten |
% van het totaal |
|
Fortis Investment Management SA |
2.756.357 |
8,84% |
|
Omega Pharma NV* |
7.500.000 |
24,04% |
|
Couckinvest NV / Coucke* |
3.858.080 |
12,37% |
|
Arseus NV (eigen aandelen) |
973.915 |
3,12% |
|
KBC Asset Management NV |
958.749 |
3,07% |
|
Publiek |
15.148.020 |
48,56% |
Openbaarmaking van ontvangen kennisgeving
| Source: Fagron NV
Recommended Reading
-
Regulated information Nazareth (Belgium)/Rotterdam (The Netherlands), 16 April 2026 – 6 PM CET Disclosure of transparency notifications from BlackRock, Inc. Pursuant to the Belgian act of 2 May...
Read More -
Regulated informationNazareth (Belgium)/Rotterdam (The Netherlands), 10 April 2026 – 7 AM CEST Fagron convenes Ordinary and Extraordinary General Meeting on 11 May 2026 Fagron NV invites its...
Read More